[1]
|
Balch, C.M., Gershenwald, J.E., Soong, S.J., Thompson, J.F., Atkins, M.B., Byrd, D.R., Buzaid, A.C., Cochran, A.J., Coit, D.G., Ding, S., Eggermont, A.M., Flaherty, K.T., Gimotty, P.A., Kirkwood, J.M., McMasters, K.M., Mihm Jr., M.C., Morton, D.L., Ross, M.I., Sober, A.J. and Sondak, V.K. (2009) Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of Clinical Oncology, 27, 6199-6206. http://dx.doi.org/10.1200/JCO.2009.23.4799
|
[2]
|
National Comprehensive Cancer Network (2011) Melanoma. Version 4. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).
|
[3]
|
National Comprehensive Cancer Network (2013) Melanoma. Version 2. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).
|
[4]
|
National Comprehensive Cancer Network (2016) Melanoma. Version 1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).
|
[5]
|
Bedrosian, I., Faries, M.B., Guerry 4th, D., Elenitsas, R., Schuchter, L., Mick, R., Spitz, F.R., Bucky, L.P., Alavi, A., Elder, D.E., Fraker, D.L. and Czerniecki, B.J. (2000) Incidence of Sentinel Node Metastasis in Patients with Thin Primary Melanoma (< or =1 mm) with Vertical Growth Phase. Annals of Surgical Oncology, 7, 262-267. http://dx.doi.org/10.1007/s10434-000-0262-z
|
[6]
|
Bleicher, R.J., Essner, R., Foshag, L.J., Wanek, L.A. and Morton, D.L. (2003) Role of Sentinel Lymphadenectomy in Thin Invasive Cutaneous Melanomas. Journal of Clinical Oncology, 21, 1326-1331. http://dx.doi.org/10.1200/JCO.2003.06.123
|
[7]
|
Kesmodel, S.B., Karakousis, G.C., Botbyl, J.D., Canter, R.J., Lewis, R.T., Wahl, P.M., Terhune, K.P., Alavi, A., Elder, D.E., Ming, M.E., Guerry, D., Gimotty, P.A., Fraker, D.L., Czerniecki, B.J. and Spitz, F.R. (2005) Mitotic Rate as a Predictor of Sentinel Lymph Node Positivity in Patients with Thin Melanomas. Annals of Surgical Oncology, 12, 449-458. http://dx.doi.org/10.1245/ASO.2005.04.027
|
[8]
|
Wong, S.L., Brady, M.S., Busam, K.J. and Coit, D.G. (2006) Results of Sentinel Lymph Node Biopsy in Patients with Thin Melanoma. Annals of Surgical Oncology, 13, 302-309. http://dx.doi.org/10.1245/ASO.2006.02.021
|
[9]
|
Ranieri, J.M., Wagner, J.D., Wenck, S., Johnson, C.S. and Coleman 3rd, J.J. (2006) The Prognostic Importance of Sentinel Lymph Node Biopsy in Thin Melanoma. Annals of Surgical Oncology, 13, 927-932. http://dx.doi.org/10.1245/ASO.2006.04.023
|
[10]
|
Wright, B.E., Scheri, R.P., Ye, X., Faries, M.B., Turner, R.R., Essner, R. and Morton, D.L. (2008) Importance of Sentinel Lymph Node Biopsy in Patients with Thin Melanoma. JAMA Surgery, 143, 892-899; Discussion 899-900. http://dx.doi.org/10.1001/archsurg.143.9.892
|
[11]
|
Vermeeren, L., Van der Ent, F., Sastrowijoto, P. and Hulsewé, K. (2010) Sentinel Lymph Node Biopsy in Patients with Thin Melanoma: Occurrence of Nodal Metastases and Its Prognostic Value. European Journal of Dermatology, 20, 30-34.
|
[12]
|
Murali, R., Haydu, L.E., Quinn, M.J., Saw, R.P.M., Shannon, K., Spillane, A.J., Stretch, J.R., Thompson, J.F. and Scolyer, R.A. (2012) Path Sentinel Lymph Node Biopsy in Patients with Thin Primary Cutaneous Melanoma. Annals of Surgery, 255, 128-133. http://dx.doi.org/10.1097/SLA.0b013e3182306c72
|
[13]
|
Hinz, T., Ahmadzadehfar, H., Wierzbicki, A., Holler, T., Wenzel, J., Biersack, H.J., Bieber, T. and Schmid-Wendtner, M.H. (2012) Prognostic Value of Sentinel Lymph Node Biopsy in 121 Low-Risk Melanomas (Tumor Thickness < 1.00 mm) on the Basis of a Long-Term Follow-Up. European Journal of Nuclear Medicine and Molecular Imaging, 39, 581-588. http://dx.doi.org/10.1007/s00259-011-2009-4
|
[14]
|
Han, D., Yu, D., Zhao, X., Marzban, S.S., Messina, J.L., Gonzalez, R.J., Cruse, C.W., Sarnaik, A.A., Puleo, C., Sondak, V.K. and Zager, J.S. (2012) Sentinel Node Biopsy Is Indicated for Thin Melanomas ≥ 0.76 mm. Annals of Surgical Oncology, 19, 3335-3342. http://dx.doi.org/10.1245/s10434-012-2469-1
|
[15]
|
Cascinelli, N., Belli, F., Santinami, M., Fait, V., Testori, A., Ruka, W., et al. (2000) Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience. Annals of Surgical Oncology, 7, 469-474. http://dx.doi.org/10.1007/s10434-000-0469-z
|
[16]
|
Mraz-Gernhard, S., Sagebiel, R.W., Kashani-Sabet, M., Miller III, J.R. and Leong, S.P. (1998) Prediction of Sentinel Lymph Node Micrometastasis by Histological Features in Primary Cutaneous Malignant Melanoma. Archives of Dermatology, 134, 983-987. http://dx.doi.org/10.1001/archderm.134.8.983
|
[17]
|
Joseph, E., Brobeil, A., Glass, F., Glass, J., Messina, J., DeConti, R., et al. (1998) Results of Complete Lymph Node Dissection in 83 Melanoma Patients with Positive Sentinel Nodes. Annals of Surgical Oncology, 5, 119-125. http://dx.doi.org/10.1007/BF02303844
|
[18]
|
Gershenwald, J.E., Thompson, W., Mansfield, P.F., Lee, J.E., Colome, M.I., Tseng, C.H., Lee, J.J., Balch, C.M., Reintgen, D.S. and Ross, M.I. (1999) Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients. Journal of Clinical Oncology, 17, 976-983.
|
[19]
|
Wagner, J.D., Gordon, M.S., Chuang, T.Y., Coleman, J.J., Hayes, J.T., Jung, S.-H. and Love, C. (2000) Predicting Sentinel and Residual Lymph Node Basin Disease after Sentinel Lymph Node Biopsy for Melanoma. Cancer, 89, 453-462. http://dx.doi.org/10.1002/1097-0142(20000715)89:2<453::AID-CNCR34>3.0.CO;2-V
|
[20]
|
Nguyen, C.L., McClay, E.F., Cole, D.J., O’Brien, P.H., Gillanders, W.E., Metcalf, J.S., Maize, J.C. and Baron, P.L. (2001) Melanoma Thickness and Histology Predict Sentinel Lymph Node Status. The American Journal of Surgery, 181, 8-11. http://dx.doi.org/10.1016/S0002-9610(00)00533-X
|
[21]
|
McMasters, K.M., Wong, S.L., Edwards, M.J., Ross, M.I., Chao, C., Noyes, R.D., Viar, V., Cerrito, P.B. and Reintgen, D.S. (2001) Factors That Predict the Presence of Sentinel Lymph Node Metastasis in Patients with Melanoma. Surgery, 130, 151-156. http://dx.doi.org/10.1067/msy.2001.115830
|
[22]
|
Rousseau Jr., D.L., Ross, M.I., Johnson, M.M., Prieto, V.G., Lee, J.E., Mansfield, P.F. and Gershenwald, J.E. (2003) Revised American Joint Committee on Cancer Staging Criteria Accurately Predict Sentinel Lymph Node Positivity in Clinically Node-Negative Melanoma Patients. Annals of Surgical Oncology, 10, 569-574. http://dx.doi.org/10.1245/ASO.2003.09.016
|
[23]
|
Sondak, V.K., Taylor, J.M., Sabel, M.S., Wang, Y., Lowe, L., Grover, A.C., et al. (2004) Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned from the Generation of a Probabilistic Model. Annals of Surgical Oncology, 11, 247-258. http://dx.doi.org/10.1245/ASO.2004.03.044
|
[24]
|
Thompson, J.F. and Shaw, H.M. (2004) Editorial: Should Tumor Mitotic Rate and Patient Age, as Well as Tumor Thickness, Be Used to Select Melanoma Patients for Sentinel Node Biopsy? Annals of Surgical Oncology, 11, 233-235. http://dx.doi.org/10.1245/ASO.2004.01.912
|